1. Arata J, Hatakenaka K, Oono T. Effect of topical application of glycine and proline on recalcitrant leg ulcers of prolidase deficiency. Arch Dermatol. 1986;122:626–7.
2. Bissonnette R, Friedmann D, Giroux JM, Dolenga M, Hechtman P, Der Kaloustian VM, Dubuc R. Prolidase deficiency: a multisystemic hereditary disorder. J Am Acad Dermatol. 1993;29(5 Pt 2):818–21.
3. Buist NRM, Strandholm JJ, Bellinger JF, et al. Further studies on a patient with iminodipeptiduria: a probable case of prolidase deficiency. Metabolism. 1972;21:1113–23.
4. Forlina A, Luupi A, Vaghi P, et al. Mutation analysis of five new patients affected by prolidase deficiency; the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts. Hum Genet. 2002;111:3114–22.
5. Hechtman P, Richter A, Corman N, et al. In situ activation of human erythrocyte prolidase. Potential for enzyme replacement therapy. Pediatr Res. 1988;24:709–12.